It is unlikely that MIB2 limits dermatitis by suppressing IL-12 signaling, as the administration of IL-12 resolves the dermatitis of Sharpincpdm mice up to 3 weeks post administration (9), and some clinical evidence suggests a protective role for IL-12 in psoriasis patients (34). Here, MIB2 is linked to skin disorder.